IBEC’s Molecular and Cellular Neurobiotechnology group is to receive funding from 2013’s La Marató de TV3 for their project “Role of the cellular prion protein as “cross-talk” protein between a-syn/ LRRK2 and p-Tau in sporadic and familiar Parkinson´s disease.”
The group’s proposal was one of 44 selected for funding under the annual award, which in its 2013 call focused on neurodegenerative diseases.
Group leader José Antonio del Rio (left) attended the official award ceremony in l’Auditori de l’Acadèmia de Ciències Mèdiques i de la Salut de Catalunya i Balears yesterday.
The project, which is a collaboration between researchers at IBEC, the University of Barcelona and Vall d’Hebron Research Institute (VHIR, will study the relationship between Parkinson’s with dementia and Alzheimer’s diseases. Specifically, it will focus on the cellular prion protein (PrPc) as a “cross-talk” protein between amyloid-beta and p-Tau, which contribute to Alzheimer’s by forming plaques or creating tangles inside affected neurons respectively, to try to determine the role it plays in Parkinson’s disease.
The Marató awards are made possible by the Fundació La Marató de TV3, which, together with Televisió de Catalunya, broadcasts an annual telethon to raise funds for scientific research into various diseases, with a different theme each year.